Arizona State University will grant Craig Venter an honorary doctorate at its commencement ceremony on May 10. Venter is chairman and CEO of the J. Craig Venter Institute.
Steven Block and Jeffrey Dangl are among 72 new members elected to the National Academy of Sciences. Block is a professor of applied physical and biological sciences at Stanford University, and published a paper on single-molecule sequencing last year (see GenomeWeb News 08/14/2006)
Dangl is John N. Couch distinguished professor at the University of North Carolina, Chapel Hill, and associate director of the Carolina Center for Genome Sciences.
Kevin Krenitsky has become CEO of genomics services firm BioServe. Prior to joining BioServe, Krenitsky was CEO of Parkway Clinical Laboratories, a clinical diagnostic testing lab. Prior to that, he was senior vice president and division head at SeraCare Life Sciences’ Genomics Collaborative biobanking division. Krenitsky was medical director at Genomics Collaborative before it was acquired by SeraCare in 2004. Last week, BioServe acquired the Genomics Collaborative business from SeraCare for an undisclosed sum.
Krenitsky replaces Ramakrishna Modali. Modali, who founded BioServe, is now listed on the company’s website as president.
Valeant Pharmaceuticals has elected former Solexa director G. Mason Morfit to its board of directors. Morfit is a partner with ValueAct Capital, Valeant's largest stockholder. Prior to joining ValueAct, Morfit worked in equity research for Credit Suisse First Boston.
NanoString Technologies has appointed Jonathan Roy as vice president of sales.
Roy comes to NanoString from Alfa Wassermann Proteomic Technologies, where he was vice president of commercial operations. Previously, he was regional business manager for the Southeastern US for Roche Applied Science, North American sales manager for Dynal Biotech’s molecular division, and held a variety of sales management positions at Applied Biosystems.